(Q69866226)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Tumour inhibitory effects of TCGF/IL-2/-containing preparations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

J Bubeník

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

M Indrová

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

P Perlmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

K Berzins

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

O Mach

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

J Kraml

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

A Toulcová

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

6 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

57-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3872165%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00199313

6 October 2019

exact match

0 references

cites work

The reproducibility of fast protein liquid chromatography of pyridoxalated haemoglobin copolymerized with serum albumin

1 reference

12 December 2020

Growth inhibition of an MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations. Preliminary report

1 reference

12 December 2020

T cell growth factor: parameters of production and a quantitative microassay for activity

1 reference

12 December 2020

Interleukin-2 augments natural killer cell activity

1 reference

12 December 2020

Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity

1 reference

12 December 2020

Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity

1 reference

12 December 2020

Phorbol myristate acetate and in vitro T lymphocyte function. I. PMA may contaminate lymphokine preparations and can interfere with interleukin bioassays

1 reference

12 December 2020

T-cell growth factor contains activity that supports natural killer activity in vitro

1 reference

12 December 2020

Properties of sodium dodecyl sulfate-denatured Interleukin 2

1 reference

12 December 2020

Solubilized tumour-associated antigens of methyl-cholanthrene-induced mouse sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests

1 reference

12 December 2020

Biochemical and biologic characterization of lymphocyte regulatory molecules. IV. Purification of Interleukin 2 from a murine T cell lymphoma

1 reference

12 December 2020

Continuous cytotoxic T-cell lines

1 reference

12 December 2020

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

1 reference

12 December 2020

T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice

1 reference

12 December 2020

Fast protein liquid chromatography of pyridoxalated and glutaraldehyde-treated human haemoglobin

1 reference

12 December 2020

Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines

1 reference

12 December 2020

Passive immunity in mice against C57BL leukosis E.L. 4 by means of iso-immune serum

1 reference

12 December 2020

Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines

1 reference

12 December 2020

1 reference

12 December 2020

T-Cell Growth Factor and the Culture of Cloned Functional T Cells

1 reference

12 December 2020

Clearance of interleukin 2 from the blood of normal and T cell-depleted mice

1 reference

12 December 2020

In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells

1 reference

12 December 2020

The fate of interleukin-2 after in vivo administration

1 reference

12 December 2020

Phorbol myristate acetate-stimulated production of interleukin 2 by T-cell lymphoma and constitutive production by derived hybridomas

1 reference

12 December 2020